글로벌 피브리노겐 테스트 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 피브리노겐 테스트 시장

피브리노겐 검사 시장은 2021년에서 2028년까지의 예측 기간 동안 7.22%의 시장 성장을 보일 것으로 예상되며 2028년까지 1,904.42백만 달러에 도달할 것으로 추산됩니다. 피브리노겐 검사 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 자동화되고 기술적으로 진보된 응고 기구의 채택률이 증가함에 따라 피브리노겐 검사 시장 성장이 가속화되고 있습니다.

피브리노겐은 척추동물의 혈액 순환에 중요한 신체의 중요한 당단백질입니다. 혈관과 조직이 자연과 관련된 부상 중에 이들은 트롬빈 에 의해 효소적으로 피브린으로 변환됩니다. 피브리노겐은 척추동물의 혈액을 순환시키는 데 사용되는 당단백질의 한 유형이며 신체의 응고를 담당하는 요인입니다. 피브리노겐 검사는 신체의 비정상적인 출혈 의 원인을 결정하는 데 사용됩니다 .

예측 기간 동안 피브리노겐 검사 시장의 성장을 촉진할 것으로 예상되는 주요 요인은 만성 질환, 사고 및 당뇨병과 같은 라이프스타일 질환의 발생률 증가, 일반 인구 증가 및 설탕 소비 증가입니다. 반면, 피브리노겐 검사 장비 비용의 상승은 타임라인 기간 동안 피브리노겐 검사 시장의 성장을 더욱 방해할 것으로 예상됩니다.

또한, 충족되지 않은 진단 요구 사항 의 발생률 증가는 향후 몇 년 동안 피브리노겐 검사 시장 성장에 유리한 기회를 더욱 제공할 것입니다. 그러나 선진 국가의 경계 부족은 가까운 미래에 시장 성장에 더욱 도전이 될 수 있습니다.

This fibrinogen testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on fibrinogen testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Fibrinogen Testing Market Scope and Market Size

The fibrinogen testing market is segmented on the basis of reagent type, indication, product type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of reagent type, the fibrinogen testing market is segmented into Q.F.A. thrombin kits, fibrinogen kits, multifibren ureagents, STA-fibrinogen kits, imidazole buffer kits.
• On the basis of indication, the fibrinogen testing market is segmented into congenital fibrinogen disorders, fibrinogen storage diseases, hereditary fibrinogen α-chain amyloidosis, acquired dysfibrinogenemia, cryofibrinogenemia, disseminated intravascular coagulation, end-stage liver disease.
• On the basis of product type, the fibrinogen testing market is segmented into heat precipitation test, clotting method, immunoassays, DNA tests.
• On the basis of end user, the fibrinogen testing market is segmented into hospitals, clinics, diagnostic laboratories, ambulatory care centers, academics and research institutes

Fibrinogen Testing Market Country Level Analysis

The fibrinogen testing market is analysed and market size insights and trends are provided by country, reagent type, indication, product type and end user as referenced above.      

The countries covered in the fibrinogen testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the fibrinogen testing market due to the rise in the incidences of diabetes, illnesses like cancer. Furthermore, the increasing of the healthcare programs will further boost the growth of fibrinogen testing market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the fibrinogen testing market due to the increase in the disposable incomes. Moreover, the rise in the admittance to healthcare and the development of testing centers is further anticipated to propel the growth of the fibrinogen testing market in the region in the coming years.

The country section of the fibrinogen testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The fibrinogen testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for fibrinogen testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the fibrinogen testing market. The data is available for historic period 2010-2019.

Competitive Landscape and Fibrinogen Testing Market Share Analysis

The fibrinogen testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to fibrinogen testing market.

피브리노겐 검사 시장 보고서에 포함된 주요 기업은 F. Hoffmann-La Roche Ltd, Abbott, Siemens, CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems, Instrumentation Laboratory India Pvt ltd, Sienco, Inc., SenGenix., Universal Biosensors, RUSNANO Group, Coagulation Sciences LLC, Tcoag Ireland, SEKISUI MEDICAL CO., LTD., Thermo Fisher Scientific, NIHON KOHDEN CORPORATION., Biosystems Pvt. Ltd., Maccura Biotechnology Co., Horiba Ltd., Sysmex Corporation 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-44859